An exciting update from Cancer Tech Accelerator on the six project teams they have accepted onto Phase II. We are looking forward to seeing them pitch at the demo day in October. More details about the announcement 👇
We've just announced that six project teams from our 2024 cohort have been accepted onto Phase II of the accelerator! These six teams were selected from the 25 that took part in Phase I. Three of them will receive a £70,000 grant to continue developing their tech, while three more Rising Stars will benefit from four months of mentorship and training. “The Phase II selection was made by an expert panel including renowned cancer researchers, tech specialists, and health and biotech investors," says Lotus Qi, Head of MedTech at Capital Enterprise. "We congratulate all the successful teams, both those which received funding and our Rising Stars. To everyone who participated in Phase I, we look forward to welcoming them into our growing community of medtech founders.” Read more about the six project teams that will continue onto Phase II 👇 https://lnkd.in/ecgvGv3D Cancer Tech Accelerator is funded by Cancer Research UK (CRUK) with grant funding support from Cancer Research Horizons, The Brain Tumour Charity and HGF Limited, with further support from Blood Cancer UK LifeArc and Roche. #innovation #oncology #research #spinout #cancer #beatcancer #accelerator #cancerresearch #entrepreneur